Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer (INSEAN)

Omphis Foundation

Status: Enrolling

Conditions: Breast Cancer

Treatments: Other: Application of green indocyanine colorant; Drug: Technetium99

Study type: Observational

Funder types: Other

Identifiers

NCT06378944

61/23

Details and patient eligibility

About

The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.

Full description

In the operating room 1 ml of indocyaninge grenn will be injectec periareolar . After 5 minutes the lymph node will be detected and extracted. The comparison between the lymph nodes detected with Technetium 99 and indocyanine green will be analysed.

Enrollment: 15,000 estimated patients

Sex: All

Ages: 18 to 120 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients >18 years of age with breast cancer who are candidates for sentinel lymph node detection will be included.
• N0 patients or patients who have undergone target axillary detection with good response

Exclusion criteria

• Lymphadenectomy